|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/12/16 Positiveid Corp 10-K 12/31/15 83:9.9M M2 Compliance/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.04M
2: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 136K
3: EX-10.74 Material Contract HTML 83K
4: EX-10.75 Material Contract HTML 62K
5: EX-10.76 Material Contract HTML 62K
6: EX-10.77 Material Contract HTML 39K
7: EX-10.78 Material Contract HTML 96K
8: EX-10.79 Material Contract HTML 132K
9: EX-10.80 Material Contract HTML 60K
10: EX-10.81 Material Contract HTML 62K
11: EX-21.1 Subsidiaries List HTML 23K
12: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
13: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
20: R1 Document and Entity Information HTML 52K
21: R2 Consolidated Balance Sheets HTML 107K
22: R3 Consolidated Balance Sheets (Parenthetical) HTML 56K
23: R4 Consolidated Statements of Operations HTML 79K
24: R5 Consolidated Statements of Changes in HTML 88K
Stockholders' Deficit
25: R6 Consolidated Statements of Cash Flows HTML 139K
26: R7 Organization HTML 36K
27: R8 Summary of Significant Accounting Policies HTML 94K
28: R9 Inventories HTML 32K
29: R10 Acquisitions/Dispositions HTML 78K
30: R11 Intangible Assets HTML 43K
31: R12 Deferred Revenue HTML 28K
32: R13 Accrued Expenses HTML 30K
33: R14 Equity and Debt Financing Agreements HTML 207K
34: R15 Stockholders' Deficit HTML 127K
35: R16 Income Taxes HTML 53K
36: R17 Commitments and Contingencies HTML 36K
37: R18 Employment Contracts and Stock Compensation HTML 39K
38: R19 Agreements with The Boeing Company HTML 29K
39: R20 Subsequent Events HTML 40K
40: R21 Summary of Significant Accounting Policies HTML 164K
(Policies)
41: R22 Summary of Significant Accounting Policies HTML 45K
(Tables)
42: R23 Inventories (Tables) HTML 31K
43: R24 Acquisitions/Dispositions (Tables) HTML 51K
44: R25 Intangible Assets (Tables) HTML 45K
45: R26 Accrued Expenses (Tables) HTML 30K
46: R27 Equity and Debt Financing Agreements (Tables) HTML 80K
47: R28 Stockholders' Deficit (Tables) HTML 100K
48: R29 Income Taxes (Tables) HTML 44K
49: R30 Organization (Details Narrative) HTML 35K
50: R31 Summary of Significant Accounting Policies HTML 80K
(Details Narrative)
51: R32 Summary of Significant Accounting Policies - HTML 50K
Schedule of Equipment (Details)
52: R33 Summary of Significant Accounting Policies HTML 44K
(Details)
53: R34 Inventories - Schedule of Inventory Net (Details) HTML 34K
54: R35 Acquisitions/Dispositions (Details Narrative) HTML 161K
55: R36 Acquisitions/Dispositions - Schedule of Asset and HTML 45K
Liabilities Acquired (Details)
56: R37 Acquisitions/Dispositions - Schedule of Business HTML 30K
Acquisitions by Acquisition, Contingent
Consideration (Details)
57: R38 Acquisitions/Dispositions - Schedule of HTML 31K
Supplemental Pro Forma Information (Details)
58: R39 Intangible Assets (Details Narrative) HTML 28K
59: R40 Intangible Assets - Schedule of Intangible Assets HTML 38K
(Details)
60: R41 Intangible Assets - Schedule of Intangible Assets HTML 38K
Future Amortization Expense (Details)
61: R42 Deferred Revenue (Details Narrative) HTML 27K
62: R43 Accrued Expenses - Schedule of Accrued Expenses HTML 33K
and Other Current Liabilities (Details)
63: R44 Equity and Debt Financing Agreements (Details HTML 1.57M
Narrative)
64: R45 Equity and Debt Financing Agreements - Schedule of HTML 49K
Short-term Debt (Details)
65: R46 Equity and Debt Financing Agreements - Fair Value HTML 37K
Measurements, Recurring and Nonrecurring,
Valuation Techniques (Details)
66: R47 Equity and Debt Financing Agreements - Fair Value HTML 36K
Option Quantitative Disclosures (Details)
67: R48 Equity and Debt Financing Agreements - Schedule of HTML 34K
Fair Value Assets and Liabilities Measured on
Recurring Basis (Details)
68: R49 Stockholders' Deficit (Details Narrative) HTML 200K
69: R50 Stockholders' Deficit - Schedule of Share-based HTML 53K
Compensation, Stock Options, Activity (Details)
70: R51 Stockholders' Deficit - Schedule of Share-based HTML 70K
Compensation, Shares Authorized under Stock Option
Plans, by Exercise Price Range (Details)
71: R52 Stockholders' Deficit - Schedule of Share-based HTML 40K
Payment Award, Stock Options, Valuation
Assumptions (Details)
72: R53 Stockholders' Deficit - Schedule of Nonvested HTML 35K
Restricted Stock Units Activity (Details)
73: R54 Stockholders' Deficit - Schedule of Stockholders' HTML 64K
Equity Note, Warrants or Rights (Details)
74: R55 Income Taxes (Details Narrative) HTML 50K
75: R56 Income Taxes - Schedule of Deferred Tax Assets and HTML 46K
Liabilities (Details)
76: R57 Income Taxes - Schedule of Effective Income Tax HTML 42K
Rate Reconciliation (Details)
77: R58 Commitments and Contingencies (Details Narrative) HTML 38K
78: R59 Employment Contracts and Stock Compensation to HTML 112K
Related Parties (Details Narrative)
79: R60 Agreements with The Boeing Company (Details HTML 31K
Narrativel)
80: R61 Subsequent Events (Details Narrative) HTML 121K
82: XML IDEA XML File -- Filing Summary XML 138K
81: EXCEL IDEA Workbook of Financial Reports XLSX 112K
14: EX-101.INS XBRL Instance -- psid-20151231 XML 2.45M
16: EX-101.CAL XBRL Calculations -- psid-20151231_cal XML 175K
17: EX-101.DEF XBRL Definitions -- psid-20151231_def XML 872K
18: EX-101.LAB XBRL Labels -- psid-20151231_lab XML 1.74M
19: EX-101.PRE XBRL Presentations -- psid-20151231_pre XML 1.10M
15: EX-101.SCH XBRL Schema -- psid-20151231 XSD 295K
83: ZIP XBRL Zipped Folder -- 0001493152-16-008808-xbrl Zip 219K
Exhibit 10.81
POSITIVEID CORPORATION
EMPLOYMENT AND NON-COMPETE AGREEMENT
THIS AGREEMENT (“Agreement”), made this 8th day of April, 2016 and effective as of January 1, 2016 (the “Effective Date”), is made by and between PositiveID Corporation, a Delaware corporation, having an address at 1690 S. Congress Ave., Suite 201, Delray Beach, FL 33445 (“PSID” or the “Company”), and Lyle L. Probst, having an address as specified in Section 14 (“Executive”). Hereinafter PSID and Executive may be individually referred to as “Party” and collectively referred to as “Parties”.
WHEREAS, PSID is a life sciences tools and diagnostics company with an extensive patent portfolio (the “Business”); and
WHEREAS, Executive has contributed meaningfully in his capacity as President; and
WHEREAS, PSID finds it is in its best interest to enhance Executive’s contribution to the Business, to protect its technologies and business relationships, and to continue engage Executive’s services as President of PSID; and
WHEREAS, Executive is willing to continue the fulltime role as PSID’s President.
NOW THEREFORE, in consideration of the promises and the mutual obligations set forth in this Agreement, the Parties agree as follows:
1. Employment. PSID agrees to continue to employ Executive, and Executive agrees to continue such employment by PSID, pursuant to the terms and conditions set forth in this Agreement.
2. Position and Responsibilities. During the term of this Agreement, as defined below, Executive shall serve as President of PSID and will perform such duties and exercise such supervision with regard to the business of PSID as are associated with such position, as well as such additional duties as may be reasonably prescribed from time to time by PSID’s Board of Directors (the “Board”). Executive agrees to render services to the best of Executive’s ability for and on behalf of PSID. Executive agrees to devote his full business time to rendering such services on behalf of PSID.
3. Term. Except as otherwise provided in this Section 3 of this Agreement, the term of this Agreement (the “Term”) shall commence on the Effective Date and shall continue in force thereafter for a period of three (3) years from the Effective Date. Notwithstanding the foregoing, upon the happening of any of the following events, this Agreement shall terminate (unless otherwise provided herein for a termination after a period of time) and Executive shall cease to be an employee of PSID:
| (a) | Executive’s resignation upon sixty (60) days advance written notice; |
C:
| (b) | Executive’s Total Disability upon PSID’s election. For purposes of this Agreement, “Total Disability” shall be defined as Executive’s inability, due to illness, accident or any other physical or mental incapacity, to perform Executive’s usual responsibilities performed by Executive for PSID prior to the onset of such disability, for one hundred eighty (180) consecutive days during the Term. PSID may elect, by written notice to Executive, within thirty (30) days of the end of such period of Total Disability defined above, to terminate Executive’s employment herein; | |
| (c) | The death of Executive; | |
| (d) | PSID terminates this Agreement for cause, with said cause being defined as a conviction of a felony or Executive being prevented from providing services hereunder as a result of Executive’s violation of any law, regulation and/or rule. | |
| (e) | Nothing in this Agreement is intended to limit the rights of PSID to terminate this Agreement under applicable bankruptcy laws in the event that PSID files for protection under the United States Bankruptcy Code. |
4. Annual Compensation. (a) During the Term, Executive shall be entitled to compensation for all services performed by Executive pursuant to this Agreement (“Compensation”) as follows:
| (1) | Executive shall be entitled to an initial base salary (the “Base Salary”) for the 2016 calendar year of $200,000 (two hundred thousand dollars), payable according to the customary payroll practices of PSID for the then current period. The Base Salary shall increase annually at the discretion of the Compensation Committee of the Board of Directors. The “Base Salary” shall, for all purposes of this Agreement, mean the Base Salary then being paid by PSID to Executive. | |
| (2) | The Executive’s Base Salary shall increase to $250,000 (two hundred fifty thousand dollars) at such time as the Company’s common stock is traded on a national exchange. | |
| (3) | During the Term, Executive shall be eligible to receive an annual bonus for each calendar year of an amount reasonably determined in the discretion of the Compensation Committee. |
(b) PSID shall deduct from the Compensation all taxes and other deductions which are required to be deducted or withheld under any provision of any federal, state, or local law now in effect or which may become effective at any time during the Term.
C:
| - C: 2- |
5. Fringe Benefits. During the Term, Executive shall be entitled to all fringe benefits (the “Fringe Benefits”) provided to senior executive employees of PSID, as reasonably determined by the Compensation Committee. The Fringe Benefits shall specifically include executive health benefits which shall entitle Executive to full reimbursement for all physical examinations and other related services.
6. Business and Other Expenses. PSID will reimburse Executive for all reasonable travel, entertainment and other expenses incurred by Executive in connection with the performance of his duties and obligations under this Agreement. Executive will comply with all reasonable reporting requirements with respect to business expenses as may be established by PSID from time to time.
7. Additional Benefits. (a) Executive will be entitled to participate in all other compensation or employee benefit plans or programs and receive all benefits for which salaried employees of PSID generally are eligible under any plan or program now or later established by PSID on the same basis as similarly situated senior executives of PSID. Executive will participate to the extent permissible under the terms and provisions of such plans or programs, in accordance with program provisions.
(b) PSID issued 15,000,000 (fifteen million) stock options (the “Options”) in PSID to Executive on January 7, 2016, in contemplation of this agreement. The options shall vest thirty-four percent (34%) on January 1, 2017 and thirty-three percent (33%) percent, each on January 1, 2018, and January 1, 2019.
8. Payment Upon Termination of Agreement. (a) In the event this Agreement is terminated by Executive’s resignation pursuant to subparagraph (a) or (d) of Section 3 of this Agreement, PSID will pay to Executive any and all earned but unpaid Base Salary and earned but unpaid incentive bonus compensation as of the date of termination. PSID shall pay such amounts due Executive within thirty (30) days of Executive’s last day of service. In addition, any outstanding stock options held by Executive on Executive’s last day of service shall remain exercisable for the life of the option.
(b) (i) In the event this Agreement is terminated pursuant to any of subparagraphs (b) or (c) of Section 3 of this Agreement, or if PSID terminates this Agreement without cause, PSID will, in addition to maintaining the Fringe Benefits through December 31, 2018, pay to Executive the sum of (i) any and all earned but unpaid Base Salary and earned but unpaid incentive bonus compensation as of the date of termination; (ii) the greater of (A) the Base Salary from the date of termination through December 31, 2018, or (B) one (1) times the Base Salary; and (iii) the average bonus paid by PSID to Executive for the last three (3) full calendar years (or such lesser time period if the Agreement is terminated less than three (3) years from the Effective Date) immediately prior to the date of termination (collectively, the “Termination Compensation”).
(ii) The Termination Compensation shall be paid within thirty (30) days of Executive’s last day of service. In addition, any outstanding stock options and unvested restricted shares held by Executive on Executive’s last day of service pursuant to such termination shall become vested and exercisable as of such date of termination, and will remain exercisable for the life of the option. In addition, PSID shall maintain Executive on its group medical plan on the same conditions as if he were to remain employed by PSID, until Executive is eligible to be covered under another comparable group medical plan.
C:
| -3- |
(c) (i) To the extent that during the Term there shall be Change in Control, as hereinafter defined, notwithstanding any term to the contrary in this Agreement, this Agreement shall terminate in which event, the Executive shall be entitled to receive the Change in Control Compensation, as hereafter defined.
(ii) For all purposes of this Agreement, the Term Change in Control Compensation shall mean the sum of (A) any and all earned but unpaid Base Salary and earned but unpaid bonus compensation as of the date of the Change in Control; (B) the Base Salary multiplied by 2.0 (two); and (C) the highest annual bonus paid by PSID to Executive for any of the three (3) full calendar years immediately prior to the Change in Control, multiplied by 2.0 (two). The Change in Control Compensation shall be paid to Executive within ten (10) days of the Change in Control. In addition, any outstanding stock options and unvested restricted stock held by Executive as of the Change in Control shall become vested and exercisable as of such date, and shall remain exercisable as of the life of the option.
(iii) For avoidance of confusion, in the event of a Change of Control, the Executive shall be entitled to the Change of Control Compensation and not the Termination Compensation.
(iv) For the purposes of this Section 8, a Change of Control means the happening of any of the following:
(A) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any “person” as such term is used in Section 13(d) and 14(d) of the Exchange Act (other than any trustee or other fiduciary holding securities under any employee benefit plan of the Company, or any company owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of stock of the Company), is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities entitled generally to vote in the election of the Board (other than the occurrence of any contingency);
(B) the stockholders of the Company approve a merger or consolidation of the Company with any other corporation or entity, which is consummated, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or
C:
| -4- |
(C) the effective date of a complete liquidation of the Company or the consummation of an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets, which in both cases are approved by the stockholders of the Company as may be required by law.
9. Confidential Information. (a) Executive recognizes and acknowledges that all information pertaining to this Agreement or to the affairs; business; results of operations; accounting methods, practices and procedures; shareholders; acquisition candidates; financial condition; clients; customers or other relationships of PSID or any of its affiliates (“Information”) is confidential and is a unique and valuable asset of PSID or any of its affiliates. Access to and knowledge of the Information is essential to the performance of Executive’s duties under this Agreement. Executive will not, during the Term or thereafter, except to the extent reasonably necessary in performance of his duties under this Agreement, give to any person, firm, association, corporation, or governmental agency any Information, except as may be required by law. Executive will not make use of the Information for his own purposes or for the benefit of any person or organization other than PSID or any of its affiliates. Executive will also use his best efforts to prevent the disclosure of this Information by others. All records, memoranda, etc. relating to the business of PSID or its affiliates, whether made by Executive or otherwise coming into his possession, are confidential and will remain the property of PSID or its affiliates.
(b) Executive will, with reasonable notice during or after the Term, furnish information as may be in his possession and fully cooperate with PSID and its affiliates as may be required in connection with any claims or legal action in which PSID or any of its affiliates is or may become a party.
10. Restrictions. (a) During the Term, and only to the extent that Executive submits his resignation in accordance with Section 3(a), thereafter for a two (2) year period (the “Restriction Period”), Executive agrees that, without the prior express written approval from the Board, he shall not compete with PSID and its affiliates by directly or indirectly engaging in the Business, either directly or indirectly, as an individual, partner, member, corporation, limited liability company, limited liability partnership, officer of a corporation or in any other capacity whatsoever at any location at which PSID or its affiliates conducts business and/or provides any services.
(b) Executive acknowledges that the restrictions contained in this Section 10 of this Agreement, in view of the nature of the activities in which PSID and its affiliates are engaged, are reasonable and necessary in order to protect the legitimate interests of PSID and its affiliates, and that any violation thereof would result in irreparable injuries to PSID and/or its affiliate(s), as the case may be. Executive, therefore, acknowledges that, in the event of the violation of any of these restrictions, PSID shall be entitled to obtain from any Court of competent jurisdiction preliminary and permanent injunctive relief, as well as attorney’s fees and costs, damages and an equitable accounting of all earnings, profits and other benefits arising from such violation, which rights shall be cumulative, and in addition to any other rights or remedies to which PSID may be entitled.
C:
| -5- |
(c) Executive agrees that the restrictions contained in this Section 10 of this Agreement are an essential element of Executive’s compensation that Executive is granted hereunder and, but for Executive’s agreement to comply with such restrictions, PSID would not have entered into this Agreement.
(d) If any of the restrictions set forth in this Section 10 should, for any reason, be adjudged invalid or unreasonable in any proceeding, then the validity or enforceability of the remainder of such restrictions shall not be adversely affected. If the Restriction Period or the area specified in this Section 10 of this Agreement shall be adjudged unreasonable in any proceeding, then the Restriction Period shall be reduced by such number of months, or the area shall be reduced by the elimination of such portion thereof or both, so that such restrictions may be enforced in such area and for such period of time as is adjudged to be reasonable. If Executive violates any of the restrictions contained in this Section 10, the Restriction Period shall not run in favor of Executive from the time of commencement of any such violation until such time as such violation shall be cured by Executive to the satisfaction of PSID.
(e) The terms of this Section 10 shall survive the termination of this Agreement. Executive acknowledges that he can be gainfully employed and still comply with the terms of this Section 10 and that it is not unduly inconvenient to him.
11. Indemnification; Litigation. (a) PSID will indemnify Executive to the fullest extent permitted by the laws of the State of Florida in effect at that time, or the certificate of incorporation and by-laws of PSID, whichever affords the greater protection to Executive. Executive will be entitled to any insurance policies PSID may elect to maintain generally for the benefit of its officers and directors against all costs, charges and expenses incurred in connection with any action, suit or proceeding to which he may be made a party by reason of being an officer of PSID.
(b) In the event of any litigation or other proceeding between PSID and Executive with respect to the subject matter of this Agreement, PSID will reimburse Executive for all costs and expenses related to the litigation or proceedings, including attorney’s fees and expenses, providing that the litigation or proceedings results in either a settlement requiring PSID to make a payment to Executive or judgment in favor of Executive.
12. Mitigation. Executive will not be required to mitigate the amount of any payment provided for hereunder by seeking other employment or otherwise, nor will the amount of any such payment be reduced by any compensation earned by Executive as the result of employment by another employer after the date Executive’s employment hereunder terminates.
13. Remedies. (a) In the event of a breach of this Agreement, the nonbreaching Party may maintain an action for specific performance against the Party who is alleged to have breached any of the terms of this Agreement. This subparagraph (a) of this Section 13 of this Agreement will not be construed to limit in any manner any other rights or remedies an aggrieved Party may have by virtue of any breach of this Agreement.
C:
| -6- |
(b) Each of the Parties has the right to waive compliance with any obligation of this Agreement, but a waiver by any Party of any obligation will not be deemed a waiver of compliance with any other obligation or of its right to seek redress for any breach of any obligation on any subsequent occasion, nor will any waiver be deemed effective unless in writing and signed by the Party so waiving.
14. Notices. Any notices required or permitted by this Agreement or by law to be served on, or delivered to, any Party to this Agreement, shall be in writing and shall be signed by the Party giving or delivering it and sent by courier that guarantees overnight delivery, or by registered or certified mail, return receipt requested, addressed to the Party to whom any communication under this Agreement is to be made. Notice given as provided herein shall be deemed to have been given on the mailing date and, unless otherwise provided herein, shall be effective from that date. Notice shall be sent to the respective Party at the address set forth below. Any Party may change its address for purposes of receiving notices by furnishing notice of such change in the manner set forth above.
| If to PSID: | Positive ID Corporation | |
| 1690 South Congress Avenue- Suite 201 | ||
| Delray Beach, Florida 33445 | ||
| If to Executive: | Lyle L. Probst | |
| ______________________ | ||
| ______________________ |
15. Invalid Provisions. The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof, and the Agreement shall be construed in all respects as though such invalid or unenforceable provisions were omitted.
16. Assignment. This Agreement shall inure to the benefit of and be binding upon PSID, its successors and assigns, and Executive. This Agreement, being for the personal services of Executive, shall not be assignable or subject to anticipation by Executive.
17. Amendments. The terms and provisions of this Agreement may not be modified except by written instrument duly executed by the Parties.
18. Entire Agreement. This Agreement supersedes all other oral and written agreements between the Parties with respect to the matters contained in this Agreement and, except as otherwise provided herein, this Agreement contains all of the covenants and agreements between the Parties with respect to those matters.
19. Law Governing Agreement. This Agreement shall be governed by and construed in accordance with the laws of the State of Florida. Any terms and conditions of this Agreement which apply to Executive and/or govern Executive’s behavior after Executive’s termination of employment and/or after the termination of this Agreement shall automatically survive the termination of this Agreement.
C:
| -7- |
20. Consent to Jurisdiction and Venue. The Parties hereby consent and submit to the jurisdiction and venue of any state or federal court within the State of Florida, Palm Beach County in any litigation arising out of this Agreement.
21. Captions and Gender. The headings contained in this Agreement are inserted for convenience and reference purposes only and are not intended to describe, interpret, define or limit the scope, extent or intent of this Agreement or any provisions hereof, and shall not affect in any way the meaning or interpretation of this Agreement or any provisions hereof. All personal pronouns used in this Agreement shall include the other genders whether used in the masculine or feminine or neuter gender, and the singular shall include the plural and vice versa whenever and as often as may be appropriate.
22. Counterpart Execution. This Agreement may be executed in two or more counterparts either by facsimile or otherwise, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
[Remainder Left Blank]
C:
| -8- |
IN WITNESS WHEREOF, the Parties hereto have set their hands and seals as of the date set forth on the first page of this Agreement.
| WITNESS: | POSITIVEID CORPORATION | |
| /s/ Allison F Tomek | /s/ William J Caragol | |
| Allison F. Tomek | By: William J. Caragol, CEO | |
| WITNESS: | EXECUTIVE: | |
| /s/ Edina Blazevic | /s/ Lyle L Probst | |
| Edina Blazevic | Lyle L. Probst |
C:
| -9- |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 1/1/19 | ||||
| 12/31/18 | 5 | |||
| 1/1/18 | ||||
| 1/1/17 | ||||
| Filed as of: | 4/12/16 | |||
| Filed on: | 4/11/16 | PRE 14C | ||
| 1/7/16 | 4 | |||
| 1/1/16 | ||||
| For Period end: | 12/31/15 | 10-K/A, NT 10-K | ||
| List all Filings | ||||